Work

Candida auris Testing by the Antimicrobial Resistance Laboratory Network, United States, 2022–2023

Year: 2026

Type: article

Abstract: During 2022-2023, the Antimicrobial Resistance Laboratory Network tested 8,033 Candida auris clinical isolates in the United States. Overall, 95% of isolates were fluconazole resistant, 15% amphotericin B resistant, and 1% echinocandin resistant. Laboratory capacity for C. auris identification and antifungal susceptibility testing is essential to address this emerging public health threat.

Source: Emerging infectious diseases

DOI: 10.3201/eid3202.251043

Authors: Jessica E. Laury, Kaitlin Forsberg, Elizabeth L. Berkow, Sophie Jones, D. Joseph Sexton, Dawn M. Sievert, Shawn R. Lockhart, Jeremy A.W. Gold, Meghan Lyman

Language: English

Topic: Antifungal resistance and susceptibility

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W7128536989

FWCI: 50.18

Cites: 8

Cited by: 10

Related to: